Injective, a blockchain protocol designed for decentralized finance (DeFi) derivatives trading, announced that its real-world asset (RWA) perpetual markets have surpassed $1.1 billion in trading volume so far in 2026. The platform’s latest figures indicate over $230 million in trading activity within the past month alone, with this growth covering a broad range of asset categories including equities, forex, commodities, indices, and pre-IPO markets.
Injective reports $1.1 billion RWA trading, INJ price rebounds 45% to $8.50
Surge in RWA Perpetual Markets
The RWA perpetuals offered by Injective provide traders with exposure to various traditional financial assets on-chain, using perpetual contracts that do not have fixed expiration dates. This differentiates them from standard futures contracts found in traditional finance.
This milestone signals progress in Injective’s mission to bring regulated market infrastructure onto the blockchain ecosystem and support trading beyond cryptocurrency-native assets. Trading volume for RWA perpetuals exceeded $230 million over the past month, and the cumulative year-to-date total crossed $1.1 billion, highlighting growing adoption and interest in decentralized derivatives.
The expansion of multi-asset derivatives offerings strengthens Injective’s standing in the wider on-chain RWA derivatives sector, positioning it as a leading player in this evolving landscape.
Mini dictionary: Real-world asset (RWA) perpetuals are derivatives contracts that allow traders to gain price exposure to traditional financial assets—such as equities, commodities, or currencies—on blockchain platforms. Unlike conventional futures, perpetual contracts have no fixed expiry date, enabling continuous trading and liquidity.
Injective’s RWA perpetual markets have crossed $1.1 billion in trading volume in 2026, with more than $230 million traded in the past month across major asset classes.
INJ Token Rallies, Technical Levels Watched
The INJ token, central to the Injective ecosystem, has seen renewed interest after rebounding approximately 45% from the $6.54 level. According to crypto analyst LAR, the crucial zone to monitor is the $8.50 mark. A sustained weekly close above this technical barrier could signal further bullish momentum, while failure to breach it may lead to ongoing price consolidation.
Analysts note that a move below the $6.54 area could challenge the current recovery, making this level important for assessing near-term support. Meanwhile, LAR maintains a target price of $53 for INJ over the next 120–150 days, contingent on the token achieving and holding above $8.50 and maintaining strong buying interest.
| $6.54 | Support | Critical level for sustaining recovery |
| $8.50 | Resistance | Key breakout for bullish continuation |
| $53 | Analyst target | Near previous all-time high |
Attaining the $53 target would bring INJ close to its previous all-time high of $52.62 recorded in March 2024. Traders are closely watching whether the token can achieve a decisive weekly close above $8.50 to validate the bullish scenario.
A weekly close above $8.50 is viewed as a critical trigger for further INJ upside, while repeated failure at this level could result in continued consolidation.
Sector Growth and Outlook
Growing trading volumes in Injective’s RWA perpetuals highlight expanding demand for on-chain derivatives that link traditional financial instruments with blockchain technology. However, market participants are also assessing whether increased activity on the platform translates to enhanced utility and long-term value for INJ holders.
The extent to which rising volume and network usage benefit INJ depends on factors like token utility, supply management, and the broader cryptocurrency market environment. Without corresponding protocol economics, higher trading may not always drive direct gains for token investors.
Continued development in the derivatives sector and diversity in supported asset classes could further solidify Injective’s market presence, though overall sentiment in the crypto sector will also play a decisive role.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic's $2 Trillion IPO Faces Doubts: Risks of Mismatched Computing Commitments and Revenue
The independent institution New Constructs reported that the Anthropic IPO is absurd, with a valuation of only 150 billion. The main controversy lies in the mismatch between long-term computing power commitments and clients' short-term on-demand procurement models, coupled with macroeconomic headwinds and early investor sell-off pressure, leading to increased market volatility.

Anthropic allocates 5% of shares to set up a fund before IPO, Musk calls for direct distribution to the public
Anthropic announced the establishment of a public welfare fund, initially allocating 5% of its shares. When the company's valuation increases by 50%, another 2% will be added. The aim is to address the impact of AI on employment. Musk suggested directly distributing shares to the public.

AI Stocks Struggle to Rebound: Lacking Three Major Supports, July’s Rally Hard to Replicate
JPMorgan pointed out that due to the absence of ETF bargain-hunting funds, limited room for short covering, and the early termination of the $40 billion buyback by Samsung and SK Hynix, the rebound strength of AI stocks in October may not match that of July. The resurgence of leverage risk could intensify volatility.

A Trillion-Dollar Merger Pricing Game: Market Confidence in the Merger with Tesla (TSLA.US) Hinges on SpaceX (SPCX.US) Q3 Report to Be Released on Tuesday
SpaceX's third-quarter report is regarded by the market as a potential pricing anchor for a merger: Under an all-stock swap structure, the strength of performance directly determines the persuasive power of the share exchange ratio for Tesla shareholders, while massive capital expenditures are the biggest variable shaking confidence.

